130 related articles for article (PubMed ID: 36456452)
1. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Kapoor A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
Urol Oncol; 2023 Feb; 41(2):110.e7-110.e14. PubMed ID: 36456452
[TBL] [Abstract][Full Text] [Related]
2. Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma.
Panunzio A; Sorce G; Tappero S; Hohenhorst L; Garcia CC; Piccinelli M; Tian Z; Tafuri A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Briganti A; Kapoor A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
Cancer Epidemiol; 2023 Feb; 82():102297. PubMed ID: 36401949
[TBL] [Abstract][Full Text] [Related]
3. Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era.
Culp SH; Karam JA; Wood CG
Urol Oncol; 2014 Jul; 32(5):561-8. PubMed ID: 24709415
[TBL] [Abstract][Full Text] [Related]
4. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
5. Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer.
Srivastava A; Rivera-Núñez Z; Kim S; Sterling J; Farber NJ; Radadia KD; Patel HV; Modi PK; Goyal S; Parikh R; Mayer TM; Saraiya B; Sadimin ET; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Cancer; 2020 Jul; 126(13):2991-3001. PubMed ID: 32329899
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients.
Scheipner L; Incesu RB; Morra S; Baudo A; Assad A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Tilki D; Longo N; Carmignani L; De Cobelli O; Pichler M; Ahyai S; Karakiewicz PI
Clin Genitourin Cancer; 2024 Apr; 22(2):164-170. PubMed ID: 37981546
[TBL] [Abstract][Full Text] [Related]
7. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
May M; Ficarra V; Shariat SF; Zigeuner R; Chromecki T; Cindolo L; Burger M; Gunia S; Feciche B; Wenzl V; Aziz A; Chun F; Becker A; Pahernik S; Simeone C; Longo N; Zucchi A; Antonelli A; Mirone V; Stief C; Novara G; Brookman-May S; ;
J Urol; 2013 Aug; 190(2):458-63. PubMed ID: 23434943
[TBL] [Abstract][Full Text] [Related]
8. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
9. Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma.
Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Urol Oncol; 2020 May; 38(5):537-544. PubMed ID: 32122729
[TBL] [Abstract][Full Text] [Related]
10. Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study.
Marchioni M; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Primiceri G; Berardinelli F; Briganti A; Shariat SF; Schips L; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):488-496. PubMed ID: 29229582
[TBL] [Abstract][Full Text] [Related]
11. Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities.
Deuker M; Stolzenbach F; Rosiello G; Palumbo C; Martin T; Tian Z; Chun FK; Saad F; Shariat SF; Kapoor A; Karakiewicz PI
J Urol; 2020 Oct; 204(4):671-676. PubMed ID: 32250728
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients.
Alevizakos M; Gaitanidis A; Nasioudis D; Msaouel P; Appleman LJ
Clin Genitourin Cancer; 2019 Jun; 17(3):e447-e453. PubMed ID: 30799129
[TBL] [Abstract][Full Text] [Related]
13. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
Capitanio U; Perrotte P; Zini L; Jeldres C; Shariat SF; Isbarn H; Arjane P; Peloquin F; Pharand D; Montorsi F; Karakiewicz PI
BJU Int; 2009 Sep; 104(6):795-9. PubMed ID: 19389018
[TBL] [Abstract][Full Text] [Related]
14. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
Sun M; Bianchi M; Hansen J; Abdollah F; Trinh QD; Lughezzani G; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208
[TBL] [Abstract][Full Text] [Related]
15. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
16. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
17. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time.
Bianchi M; Becker A; Hansen J; Trinh QD; Tian Z; Abdollah F; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
BJU Int; 2013 Jun; 111(8):E283-9. PubMed ID: 23714646
[TBL] [Abstract][Full Text] [Related]
18. Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma.
Tallman JE; Pearce SM; Kuchta K; Helfand BT; Eggener SE
J Urol; 2017 Nov; 198(5):1027-1032. PubMed ID: 28551443
[TBL] [Abstract][Full Text] [Related]
19. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
20. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
